NCT06178913

Brief Summary

The study goal is to develop exercise intervention methods to improve the prognosis and quality of life of patients with non-tuberculous mycobacterial lung disease and to confirm the effectiveness of exercise intervention. This prospective study is scheduled to be conducted as a pre-post single-arm feasibility trial, targeting a total of 50 subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

December 21, 2023

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2024

Completed
Last Updated

July 8, 2024

Status Verified

December 1, 2023

Enrollment Period

6 months

First QC Date

November 22, 2023

Last Update Submit

July 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • VO2max

    The patient wears a mask that transmits inhalation and exhalation to a gas analyzer on the treadmill and a heart rate monitor that measures heart rate. The treadmill gradually increases the incline and increases the speed. When the patient runs as far as they can run and raises their hand to show the measurer, the patient's VO2max is measured by measuring the maximum amount of oxygen that can be taken in and heart rate.

    within the first 1 week (plus or minus 1 week) after the end of exercise intervention

Secondary Outcomes (16)

  • The 6-Minute Walk Test

    within the first 1 week (plus or minus 1 week) after the end of exercise intervention

  • 30-Second Sit-to-Stand

    within the first 1 week (plus or minus 1 week) after the end of exercise intervention

  • Short Physical Performance Battery

    within the first 1 week (plus or minus 1 week) after the end of exercise intervention

  • Muscular strength (Handgrip strength in kilograms)

    within the first 1 week (plus or minus 1 week) after the end of exercise intervention

  • COPD Assessment Test

    within the first 1 week (plus or minus 1 week) after the end of exercise intervention

  • +11 more secondary outcomes

Study Arms (1)

Exercise intervention

EXPERIMENTAL
Other: Exercise intervention

Interventions

The exercise intervention method is a circuit training method that combines strength training and aerobic exercise forms and consists of a total of 12 movements. Performing movements 1 to 12 in order is 1 set. After completing the set, when the heart rate returns to the plateau (less than 59% of maximum heart rate), proceed to the next set, for a total of 3 sets.

Exercise intervention

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 19 to 80 years diagnosed with non-tuberculous mycobacterial lung disease according to the ATS/IDSA guideline, Patients with respiratory symptoms (cough, phlegm, difficulty breathing, etc.) at the time of selection, Patients who understand the purpose of the clinical study and voluntarily agree to participate in this clinical study

You may not qualify if:

  • Patients diagnosed with cardiovascular disease (Angina, HFrEF, arrhythmia, history of heart valve surgery, etc.), Patients who have had massive hemoptysis within the last 3 months, Patients who have difficulty moving freely due to musculoskeletal problems (osteoarthritis, intervertebral disc herniation, spinal stenosis, etc.), Patients who cannot read the consent form (e.g. illiterate, foreigner, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine

Seoul, South Korea

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2023

First Posted

December 21, 2023

Study Start

July 10, 2023

Primary Completion

January 10, 2024

Study Completion

February 20, 2024

Last Updated

July 8, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations